Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcutaneous Auricular Vagus Nerve Stimulation for Painful Diabetic Peripheral Neuropathy: A 12-Week Randomized, Double-Blind, Sham-Controlled, Parallel-Group Trial With Biomarker Endpoints

NCT06292962 is registered in ClinicalTrials.gov with Saima Abass Tahammal as lead sponsor.

NCT NCT06292962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcutaneous Auricular Vagus Nerve Stimulation for Painful Diabetic Peripheral Neuropathy: A 12-Week Randomized, Double-Blind, Sham-Controlled, Parallel-Group Trial With Biomarker Endpoints
Lead sponsor
Saima Abass Tahammal
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2025
Completion date
June 1, 2025
Enrollment
185 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic neuropathies, neuropathic pain, type2diabetes